Lauren P. Silvernail, CFO, CBO & Secretary at Revance Therapeutics, Inc. (RVNC), sold 52,886 shares at $34.50 ($1.8M) on 2018-03-13, disclosed to the SEC on 2018-03-15.
Open-market sale of $1.8M RVNC by CFO, CBO & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.50 | 25,867 | $892K | 49.0% |
| 2 | $34.50 | 25,867 | $892K | 49.0% |
| 3 | $31.65 | 1,152 | $36K | 2.0% |
| Total | $34.44 avg | 52,886 | $1.8M | 100% |
| Filing → |
| EOLS | SELL | 2022-03-10 | $198K | — | Filing → |
| EOLS | SELL | 2021-08-12 | $320K | — | Filing → |
| EOLS | SELL | 2021-01-26 | $20K | — | Filing → |